🟢 Concentrix is trading 10.13% up today as investors absorb the fiscal 2026 outlook reduction

Concentrix is trading at $30.32 (+10.13%) after investors absorbed the recent fiscal 2026 outlook reduction.

• Adjusted EPS guidance was lowered to $10.83–$11.18, below the cited $11.97 analyst estimate.
• Revenue guidance was reduced to $9.93–$10.03 billion, versus the cited $10.14 billion estimate.
• The move appears to be a relief rebound despite weaker forward expectations.